F H Sillman, A Sedlis, J G Boyce. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Acquired Immunodeficiency Syndrome/complicationsAdministration, TopicalAdultAnal Canal/pathologyAnus Neoplasms/drug therapyAnus Neoplasms/pathologyCarcinoma/drug therapyCarcinoma/pathologyCarcinoma in Situ/drug therapyCarcinoma in Situ/pathologyCarcinoma, Basal Cell/drug therapyCarcinoma, Basal Cell/pathologyCarcinoma, Squamous Cell/drug therapyCarcinoma, Squamous Cell/pathologyCervix Uteri/pathologyFemaleFluorouracil/administration & dosageFluorouracil/pharmacologyFluorouracil/therapeutic useGenital Neoplasms, Female/drug therapyGenital Neoplasms, Female/pathologyHumansImmunologic Deficiency Syndromes/complicationsImmunologic Deficiency Syndromes/congenitalKeratosis/drug therapyKeratosis/pathologyNeoplasms, Multiple Primary/drug therapyNeoplasms, Multiple Primary/pathologyPaget Disease, Extramammary/drug therapySkin/pathologySkin Neoplasms/drug therapySkin Neoplasms/pathologySyndromeUterine Cervical Neoplasms/drug therapyUterine Cervical Neoplasms/pathologyVagina/pathologyVaginal Neoplasms/drug therapyVaginal Neoplasms/pathologyVulva/pathologyVulvar Neoplasms/drug therapyVulvar Neoplasms/pathology
Substances： See more » Fluorouracil
Year: 1985 PMID： 2984615 DOI： 10.1097/00006254-198504000-00002
Source DB: PubMed Journal: Obstet Gynecol Surv ISSN： 0029-7828 Impact factor: 2.347